top
Search terms
Results 1 - 10 of 14 - ordered by :
Pages: 1 2
Ejhf

Tel: +49 551 39 2091, Fax: +49 551 39 20911, Email: s.anker@cachexia.de Search for more papers by this author Stefan Schroeder, Dan Atar, Department of Cardiology B, Oslo University Hospital Ulleval ...

European Journal of Heart Failure, Anker, Stefan D., Schroeder, Stefan, Atar, Dan, Bax, Jeroen J., Ceconi, Claudio, Cowie, Martin R., Crisp, Adam, Dominjon, Fabienne, Ford, Ian, Ghofrani, ...

Date : 01/05/2016 Item size : 212786 bytes
Ejhf

Tel: +44 255 21 21, Fax: 44 255 42 51, Email: cardiotfl@gmx.ch Search for more papers by this author Ruschitzka Frank, Editorial Office, European Heart Journal, Zurich Heart House, Zürich, ...

European Journal of Heart Failure, Lüscher, Thomas F., Ruschitzka, Frank, Landmesser, Ulf, Voors, Adriaan A., Gilst, Wiek H., Veldhuisen, Dirk J.

Date : 01/10/2012 Item size : 173285 bytes
Ejhf

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document In ASCEND-HF, specific clinical variables including older age, ...

European Journal of Heart Failure, Zannad, Faiez, Garcia, Angeles Alonso, Anker, Stefan D., Armstrong, Paul W., Calvo, Gonzalo, Cleland, John G.F., Cohn, Jay N., Dickstein, Kenneth, Domanski, Michael ...

Date : 01/10/2013 Item size : 366395 bytes
Ejhf

Following his training as a clinical pharmacologist and completing a PhD at the Austin Hospital, Krum undertook a 2-year post-doctoral fellowship at Columbia Presbyterian Medical Centre in New York ...

European Journal of Heart Failure, Gilbert, Richard E., Ruschitzka, Frank

Date : 01/02/2016
Ehjournal

In the retrospective analysis of the PROTECT trial,15 Metra and colleagues examined the association between early dyspnoea relief, defined as moderate or marked improvement at both 24 and 48 h ...

European Heart Journal, Gheorghiade, Mihai, Ruschitzka, Frank

Date : 01/06/2011
Ehjournal

Drugs inhibiting the RAAS, particularly angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), represent the cornerstone of blood pressure control and considered ...

European Heart Journal, Ruschitzka, Frank, Taddei, Stefano

Date : 01/08/2012
Ehjournal

In the retrospective analysis of the PROTECT trial,15 Metra and colleagues examined the association between early dyspnoea relief, defined as moderate or marked improvement at both 24 and 48 h ...

European Heart Journal, Gheorghiade, Mihai, Ruschitzka, Frank

Date : 01/06/2011
Ehjournal

Drugs inhibiting the RAAS, particularly angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), represent the cornerstone of blood pressure control and considered ...

European Heart Journal, Ruschitzka, Frank, Taddei, Stefano

Date : 01/08/2012 Item size : 145729 bytes
Ejhf

Tel: +1 631 444 1066, Fax: +1 631 444 1054, Email: javed.butler@stonybrookmedicine.edu Search for more papers by this author Mihai Gheorghiade, Center for Cardiovascular Innovation, Northwestern ...

European Journal of Heart Failure, Butler, Javed, Gheorghiade, Mihai, Kelkar, Anita, Fonarow, Gregg C., Anker, Stefan, Greene, Stephen J., Papadimitriou, Lampros, Collins, Sean, Ruschitzka, Frank, ...

Date : 01/11/2015 Item size : 196078 bytes
Ejhf

Tel: +49 551 39 2091, Fax: +49 551 39 20911, Email: s.anker@cachexia.de Search for more papers by this author Stefan Schroeder, Dan Atar, Department of Cardiology B, Oslo University Hospital Ulleval ...

European Journal of Heart Failure, Anker, Stefan D., Schroeder, Stefan, Atar, Dan, Bax, Jeroen J., Ceconi, Claudio, Cowie, Martin R., Crisp, Adam, Dominjon, Fabienne, Ford, Ian, Ghofrani, ...

Date : 01/05/2016 Item size : 230785 bytes